Picard Medical, Inc. 8-K

What Happened
On February 26, 2026, Picard Medical, Inc. announced via press release that it will participate in the “Hands‑On Training Day” at the Technology and Heart Failure Therapeutics 2026 conference, to be held March 1, 2026, in Boston, Massachusetts. The press release was furnished with the 8‑K as Exhibit 99.1 under Item 7.01 (Regulation FD Disclosure). The company stated that the furnished information is not being “filed” under the Securities Exchange Act.

Key Details

• Press release date: February 26, 2026.
• Event: “Hands‑On Training Day” at Technology and Heart Failure Therapeutics 2026.
• Event date and location: March 1, 2026 — Boston, Massachusetts.
• Disclosure type: Furnished under Item 7.01 (Regulation FD); press release attached as Exhibit 99.1.

Why It Matters
This 8‑K is an operational update about the company’s participation in a clinical/industry conference and does not include financial results or executive changes. For investors, it signals a public engagement by Picard Medical with clinicians and industry attendees, documented under Regulation FD; the filing clarifies the information is furnished (not “filed”) and therefore not subject to certain Exchange Act filing liabilities.